BRTX BioRestorative Therapies, Inc. - Common Stock
$0,22
Cena · Sie 25, 2026
Dane fundamentalne na dzień Maj 14, 2026
Zakres 52 tyg.
$0–$2
4% of range
Ocena Analityków
BUY
8 analysts
Cena Docelowa
$8
+3538% upside
P/E (TTM)
-0.1
ROE
-547.6%
Marża Zysku Netto
-3959.4%
BRTX Migawka akcji Cena, kapitalizacja rynkowa, P/E, EPS, ROE, zadłużenie/kapitał własny, zakres 52-tygodniowy
Cena
$0.22
Kapitalizacja Rynkowa
$2M
P/E (TTM)
-0.1
EPS (TTM)
$-1.58
Przychody (TTM)
$359.7K
Stopa dywidendy
—
ROE
-547.6%
D/E Dług/Kapitał
—
Zakres 52 tyg.
$0 – $2
BRTX Wykres ceny akcji Dzienny OHLCV ze wskaźnikami technicznymi — przesuwaj, powiększaj i dostosowuj widok
Configure
Wyniki 10-letnie Trendy przychodów, zysku netto, marż i EPS
Przychody i Zysk Netto
$359.7K
2016-12-31
→
2025-12-31
EPS
$-1.58
2022-12-31
→
2025-12-31
Wolny przepływ pieniężny
$-11M
2016-12-31
→
2025-12-31
Marże
-3959.4%
2016-12-31
→
2025-12-31
Wycena Wskaźniki P/E, P/S, P/B, EV/EBITDA — czy akcje są drogie, czy tanie?
Wskaźnik
Trend 5-letni
BRTX
Mediana porównawcza
P/E (TTM)
-0.1
—
P/S (TTM)
5.4
2.4
P/B
5.5
1.0
Price / FCF (Cena / FCF)
-0.2
—
Rentowność Marże brutto, operacyjne i netto; ROE, ROA, ROIC
Wskaźnik
Trend 5-letni
BRTX
Mediana porównawcza
Gross Margin (Marża brutto)
93.4%
66.5%
Operating Margin (Marża Operacyjna)
-4350.1%
—
Net Profit Margin (Marża Zysku Netto)
-3959.4%
-313.2%
ROA
-174.1%
-105.1%
ROE
-547.6%
-142.1%
Zdrowie finansowe Dług, płynność, wypłacalność — siła bilansu
Wskaźnik
Trend 5-letni
BRTX
Mediana porównawcza
Current Ratio (Wskaźnik bieżący)
0.8
1.6
Quick Ratio (Wskaźnik Szybkości)
0.8
—
Rozwój Wzrost przychodów, EPS i zysku netto: r/r, CAGR 3-letni, CAGR 5-letni
Wskaźnik
Trend 5-letni
BRTX
Mediana porównawcza
Revenue YoY (Przychody R/R)
-10.3%
—
Revenue CAGR 3Y (Przychody CAGR 3L)
44.3%
—
Revenue CAGR 5Y (Przychody CAGR 5L)
36.1%
—
Efektywność kapitałowa Rotacja aktywów, rotacja zapasów, rotacja należności
Wskaźnik
Trend 5-letni
BRTX
Mediana porównawcza
BRTX Konsensus analityków Bycze i niedźwiedzie opinie analityków, 12-miesięczny cel cenowy, potencjał wzrostu
KUP
8 analityków
- Mocne kupno 2 25,0%
- Kup 5 62,5%
- Trzymaj 1 12,5%
- Sprzedaj 0 0,0%
- Mocna sprzedaż 0 0,0%
12-miesięczny cel cenowy
2 analityków · 2026-08-20
Mediana
$8.00
← Poniżej wszystkich celów
$0.22
Niski
$1.00
Wysoki
$15.00
Średni cel
$8.00
+3538,0%
Średnia cel
$8.00
+3538,0%
Historia zysków EPS faktyczny vs szacowany, zaskoczenie %, wskaźnik trafień, data następnych wyników
Średnie zaskoczenie
0.01%
| Okres | EPS Actual | EPS Szacowany | Niespodzianka |
|---|---|---|---|
| 31 marca 2026 | $-0.12 | $-0.20 | 0.08% |
| 31 grudnia 2025 | $-0.31 | $-0.38 | 0.07% |
| 30 września 2025 | $-0.33 | $-0.37 | 0.04% |
| 30 czerwca 2025 | $-0.30 | $-0.39 | 0.09% |
| 31 marca 2025 | $-0.64 | $-0.33 | -0.31% |
| 31 grudnia 2024 | $-0.20 | $-0.28 | 0.08% |
Porównanie z porównywalnymi firmami (podbranża GICS) Kluczowe metryki w porównaniu do konkurentów z sektora
| Ticker | Kapitalizacja Rynkowa | P/E | Przychody r/r | Marża Netto | ROE | Marża brutto |
|---|---|---|---|---|---|---|
| BRTX | $10M | -0.7 | -10.3% | -3959.4% | -547.6% | 93.4% |
| CDIO | — | — | — | — | — | — |
| XBIO | — | -1.4 | 19.0% | — | — | — |
| PMCB | $8M | -0.3 | — | — | -56.7% | — |
| DRMA | — | — | — | — | — | — |
| BCAB | — | -0.6 | — | — | — | — |
| LABT | — | — | — | — | — | — |
| APVO | $9M | -0.1 | — | — | -217.2% | — |
| GOVX | $296.2K | — | -37.1% | -862.3% | -645.9% | — |
| SBFM | — | — | — | — | — | — |
Pełne podstawowe wskaźniki Wszystkie wskaźniki roczne — rachunek zysków i strat, bilans, przepływy pieniężne
Rachunek zysków i strat 18
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $359.7K | $401.0K | $145.8K | $119.8K | $46.0K | $77.0K | $130.0K | $111.0K | $81.0K | $36.4K | $628.9K | $416.0K | |
| Cost of Revenue | $23.8K | $28.1K | · | · | · | · | · | · | · | $102 | $261.5K | $213.8K | |
| Gross Profit | $335.9K | $372.9K | $145.8K | · | · | · | · | · | $81.0K | $36.3K | $367.4K | $202.2K | |
| R&D Expense | $10M | $7M | $4M | $4M | $729.1K | $876.8K | $2M | $2M | $2M | $3M | $2M | $1M | |
| SG&A Expense | $6M | $5M | $11M | $16M | $26M | $2M | $5M | $4M | $4M | $3M | $4M | $2M | |
| Operating Expenses | $16M | $12M | $15M | $19M | $26M | $3M | $9M | $8M | $8M | $8M | $8M | $5M | |
| Operating Income | $-16M | $-12M | $-15M | $-19M | $-26M | $-3M | $-8M | $-8M | $-8M | $-8M | $-7M | $-5M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | · | $263.6K | $285.3K | |
| Interest Income | $270.6K | $623.8K | $569.1K | $76.0K | · | · | · | · | · | · | · | · | |
| Other Non-op | $17.4K | $150.8K | $169.7K | $107.1K | · | $-9M | $-6M | $-5M | $-1M | $-851.2K | $-753.1K | $-665.1K | |
| Pretax Income | $-14M | $-9M | · | · | · | · | · | · | $-9M | $-9M | $-8M | $-6M | |
| Income Tax | · | · | · | · | · | · | · | · | · | · | · | $0 | |
| Net Income | $-14M | $-9M | $-10M | $-13M | $-44M | $-11M | $-15M | $-13M | $-9M | $-9M | $-8M | $-6M | |
| EPS (Basic) | $-1.58 | $-1.16 | $-2.47 | $-3.65 | $-37.30 | · | · | · | · | · | · | · | |
| EPS (Diluted) | $-1.58 | $-1.16 | $-2.47 | $-3.65 | · | · | · | · | · | · | · | · | |
| Shares (Basic) | 8,993,115 | 7,763,932 | 4,218,347 | 3,617,858 | 1,187,741 | · | · | · | · | · | · | · | |
| Shares (Diluted) | 8,993,115 | 7,763,932 | 4,218,347 | 3,617,858 | · | · | · | · | · | · | · | · | |
| EBITDA | $-16M | $-12M | · | $-19M | $-26M | $-3M | $-8M | $-7M | $-8M | $-8M | $-7M | $-5M |
Bilans 26
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $2M | $547.9K | $884.4K | $2M | $21M | $3M | $1.7K | $117.5K | $451.7K | $31.8K | $166.6K | $91.8K | |
| Short-term Investments | $1M | $10M | $10M | $13M | · | · | · | · | · | · | · | · | |
| Receivables | $15.5K | $188.4K | $19.3K | $16.0K | $5.0K | $17.0K | $32.0K | $29.0K | $38.0K | $6.0K | $93.4K | $0 | |
| Inventory | · | · | · | · | · | · | · | · | · | · | · | $1.9K | |
| Prepaid Expense | $168.4K | $223.2K | $305.2K | $363.1K | $436.2K | $105.4K | $35.2K | $34.5K | $30.0K | $35.6K | $29.3K | $22.5K | |
| Current Assets | $3M | $11M | $11M | $15M | $21M | $3M | $68.9K | $181.0K | $519.7K | $73.4K | $289.3K | $114.3K | |
| PP&E (Net) | $358.8K | $362.9K | $356.1K | $261.0K | $38.0K | $21.9K | $68.4K | $175.2K | $327.8K | $508.6K | $643.1K | $493.9K | |
| PP&E (Gross) | $2M | $1M | $1M | $1M | $931.6K | $900.9K | $900.9K | $865.3K | $953.8K | $950.2K | $940.7K | $651.6K | |
| Accum. Depreciation | $1M | $1M | $1M | $935.8K | $893.6K | $879.0K | $832.5K | $690.0K | $626.0K | $441.6K | $297.6K | $157.8K | |
| Intangibles | $534.2K | $623.9K | $713.7K | $803.4K | $589.7K | $664.3K | $739.2K | $814.1K | $889.0K | $963.8K | $1M | $1M | |
| Total Assets | $4M | $12M | $13M | $16M | $22M | $4M | $1M | $1M | $2M | $2M | $2M | $2M | |
| Accounts Payable | $1M | $483.1K | $189.4K | $170.9K | $50.8K | $118.9K | $2M | $2M | $2M | $2M | $3M | $1M | |
| Accrued Liabilities | · | $744.5K | $711.7K | $130.1K | $135.0K | $767.6K | $3M | $2M | $2M | $2M | $2M | $1M | |
| Short-term Debt | · | · | · | · | $59.0K | · | $7M | $4M | $3M | $2M | $1M | $6M | |
| Current Liabilities | $4M | $4M | $3M | $6M | $363.8K | $1M | $14M | $9M | $8M | $6M | $6M | $9M | |
| Capital Leases | · | · | · | $162.3K | $301.6K | $363.5K | $521.9K | · | · | · | · | · | |
| Total Liabilities | · | $4M | $3M | $6M | $856.5K | $6M | $14M | $10M | $9M | $7M | $6M | $9M | |
| Long-term Debt | · | · | · | · | $250.0K | · | · | · | · | · | · | · | |
| Total Debt | · | · | · | · | $59.0K | · | $7M | $4M | $3M | $2M | $1M | $6M | |
| Common Stock | $887 | $692 | $471 | $369 | $353 | $72 | $7.8K | $1.2K | $6.1K | $4.7K | $3.3K | $1.7K | |
| Paid-in Capital | $170M | $164M | $157M | $147M | $156M | $89M | $66M | $55M | $45M | $37M | $29M | $19M | |
| Retained Earnings | $-170M | $-156M | $-147M | $-136M | $-134M | $-90M | $-79M | $-64M | $-51M | $-42M | $-33M | $-25M | |
| Treasury Stock | · | · | · | · | · | · | · | · | · | · | $32.0K | $32.0K | |
| Stockholders' Equity | $356.7K | $9M | $10M | $10M | $11M | $-1M | $-13M | $-9M | $-7M | $-5M | $-4M | $-7M | |
| Liabilities + Equity | $4M | $12M | $13M | $16M | $22M | $4M | $1M | $1M | $2M | $2M | $2M | $2M | |
| Shares Outstanding | 8,876,242 | 6,919,919 | 4,706,917 | 3,677,775 | 3,520,391 | 715,544 | 77,851,633 | 11,728,394 | 6,112,473 | 4,699,035 | 3,310,729 | 1,697,664 |
Przepływy pieniężne 14
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $210.0K | $189.1K | $165.7K | $120.5K | $89.1K | $121.4K | $217.4K | $240.4K | $259.3K | $258.4K | $213.8K | $96.7K | |
| Stock-based Comp | $3M | $3M | $8M | $13M | $23M | $691.7K | $2M | $2M | $4M | $3M | $2M | $1M | |
| Amort. of Intangibles | $89.7K | $89.7K | $89.7K | $78.3K | $74.5K | $74.9K | · | · | · | · | · | · | |
| Other Non-cash | · | · | · | $-109.4K | $18M | $8M | $6M | $5M | $2M | $838.4K | $3M | $902.8K | |
| Operating Cash Flow | $-11M | $-8M | $-6M | $-6M | $-3M | $-2M | $-7M | $-5M | $-4M | $-5M | $-3M | $-3M | |
| CapEx | $116.1K | $106.2K | $171.0K | $265.2K | $30.7K | · | $35.6K | $12.9K | $3.6K | $188.8K | $408.1K | $168.4K | |
| Investing Cash Flow | $9M | $514.5K | $3M | $-13M | $-30.7K | · | $-35.6K | $-12.9K | $-3.6K | · | · | · | |
| Stock Issued | $3M | · | $494.8K | · | · | · | · | · | · | · | · | · | |
| Stock Repurchased | $0 | · | · | · | · | · | · | · | · | · | · | · | |
| Net Stock Activity | $3M | · | · | · | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | $3M | $7M | $2M | · | $21M | $5M | $7M | $5M | $4M | · | · | · | |
| Net Change in Cash | $963.3K | $-336.5K | $-829.4K | $-19M | $18M | $3M | $-115.9K | $-334.2K | $419.9K | · | · | · | |
| Free Cash Flow | $-11M | $-8M | · | $-6M | $-3M | · | $-7M | $-5M | $-4M | $-5M | $-4M | $-3M | |
| Levered FCF | · | · | · | · | · | · | · | · | · | · | $-4M | $-4M |
Rentowność 8
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 93.4% | 93.0% | · | · | · | · | · | · | 100.0% | 99.7% | 58.4% | 48.6% | |
| Operating Margin | -4350.1% | -2881.6% | · | -15838.1% | -57191.0% | -3574.1% | -6486.2% | -6889.8% | -10338.6% | -21447.6% | -1140.1% | -1183.3% | |
| Net Margin | -3959.4% | -2239.2% | · | -15438.0% | -96311.5% | -14639.9% | -11267.6% | -11277.3% | -11660.1% | -23755.4% | -1259.9% | -1343.2% | |
| Pretax Margin | -3947.9% | · | · | · | · | · | · | · | -11660.1% | -23755.4% | -1259.9% | -1343.2% | |
| EBITDA Margin | -4350.1% | -2881.6% | · | -15737.5% | -56997.3% | -3416.5% | -6319.0% | -6673.2% | -10018.6% | -20736.7% | -1106.1% | -1160.1% | |
| ROA | -174.1% | -72.2% | · | -95.1% | -330.6% | -387.8% | -1101.9% | -848.4% | -565.8% | -480.2% | -427.3% | -363.5% | |
| ROE | -547.6% | -97.0% | · | -144.4% | -530.0% | 137.3% | 116.2% | 142.4% | 159.6% | 193.9% | 146.8% | 82.3% | |
| ROIC | · | · | · | · | · | · | · | · | · | · | 247.4% | 410.2% |
Płynność i wypłacalność 4
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 0.8 | 3.0 | · | 34.4 | 59.0 | 3.1 | 0.0 | 0.0 | 0.1 | 0.0 | 0.1 | 0.0 | |
| Quick Ratio | 0.8 | 2.9 | · | 33.5 | 57.8 | 2.9 | 0.0 | 0.0 | 0.1 | 0.0 | 0.0 | 0.0 | |
| Debt / Equity | · | · | · | · | 0.0 | · | -0.6 | -0.4 | -0.5 | -0.4 | -0.3 | -0.8 | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | · | -27.2 | -17.3 |
Efektywność 3
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | 0.1 | 0.1 | 0.0 | 0.0 | 0.3 | 0.3 | |
| Inventory Turnover | · | · | · | · | · | · | · | · | · | · | · | 21.5 | |
| Receivables Turnover | 3.5 | 3.9 | · | 11.4 | 4.2 | 3.1 | 4.3 | 3.3 | 3.7 | 0.7 | 13.5 | · |
Stopy Wzrostu 3
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | -10.3% | 175.0% | 21.7% | 160.4% | -40.3% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 44.3% | 105.8% | 23.7% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 36.1% | · | · | · | · | · | · | · | · | · | · | · |
Wycena (TTM) 14
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $359.7K | $401.0K | $145.8K | $119.8K | $46.0K | $77.0K | $130.0K | $111.0K | $81.0K | $36.4K | $628.9K | $416.0K | |
| Net Income TTM | $-14M | $-9M | $-10M | $-13M | $-44M | $-11M | $-15M | $-13M | $-9M | $-9M | $-8M | $-6M | |
| Market Cap | $10M | $10M | · | $10M | $15M | $79.00B | $1.56B | $42.22B | $90.46B | $62.03B | $56.28B | $1.22T | |
| Enterprise Value | · | · | · | · | $-6M | · | $1.56B | $42.23B | $90.47B | $62.03B | $56.28B | $1.22T | |
| P/E | -0.7 | -1.2 | -0.7 | -0.8 | · | · | · | · | · | · | · | · | |
| P/S | 29.0 | 24.7 | · | 84.4 | 332.1 | 1025922.2 | 11977.2 | 380380.3 | 1116846.9 | 1706154.9 | 89491.3 | 2938284.1 | |
| P/B | 29.2 | 1.2 | · | 0.6 | 0.7 | -59328.9 | -121.9 | -4886.2 | -13232.5 | -12404.8 | -14400.1 | -177445.5 | |
| P / Tangible Book | · | 1.3 | 0.9 | 1.1 | 1.5 | · | · | · | · | · | · | · | |
| P / Cash Flow | -1.0 | -1.2 | · | -1.7 | -4.6 | -40216.6 | -225.0 | -8271.4 | -23474.0 | -12398.8 | -18027.3 | -378677.5 | |
| P / FCF | -1.0 | -1.2 | · | -1.6 | -4.5 | · | -223.9 | -8250.6 | -23452.0 | -11948.0 | -15943.4 | -359903.6 | |
| EV / EBITDA | · | · | · | · | 0.2 | · | -190.4 | -5700.6 | -11148.2 | -8227.9 | -8090.6 | -253287.5 | |
| EV / FCF | · | · | · | · | 1.7 | · | -224.9 | -8251.2 | -23452.8 | -11948.3 | -15943.7 | -359905.3 | |
| EV / Revenue | · | · | · | · | -123.7 | · | 12032.1 | 380412.0 | 1116884.2 | 1706205.2 | 89492.6 | 2938297.6 | |
| Earnings Yield | -134.5% | -81.1% | -142.0% | -132.7% | · | · | · | · | · | · | · | · |
Rachunek zysków i strat 16
| Wskaźnik | Trend | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $23.2K | $19.6K | $11.8K | $303.3K | $25.0K | $43.3K | $233.6K | $89.1K | $35.0K | $19.3K | $30.7K | $64.5K | $31.3K | $3.7K | $29.0K | $71.1K | |
| Cost of Revenue | $7.4K | $1.6K | $10.6K | $8.7K | $2.9K | $3.3K | $18.2K | $6.5K | · | · | · | · | · | · | · | · | |
| Gross Profit | $15.8K | $18.0K | $1.2K | $294.6K | $22.1K | $40.0K | $215.4K | $82.6K | $35.0K | $19.3K | $30.7K | $64.5K | · | · | · | · | |
| R&D Expense | $2M | $4M | $3M | $2M | $3M | $3M | $1M | $1M | $1M | $1M | $809.8K | $902.9K | $1M | $673.6K | $989.2K | $1M | |
| SG&A Expense | $1M | $283.6K | $1M | $1M | $2M | $-11.3K | $1M | $1M | $3M | $2M | $2M | $2M | $5M | $4M | $4M | $4M | |
| Operating Expenses | $3M | $4M | $4M | $4M | $5M | $3M | $3M | $3M | $4M | $3M | $3M | $3M | $6M | $5M | $5M | $5M | |
| Operating Income | $-3M | $-4M | $-4M | $-3M | $-5M | $-3M | $-2M | $-2M | $-4M | $-3M | $-3M | $-3M | $-6M | $-5M | $-5M | $-5M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $28.8K | · | |
| Interest Income | $6.1K | $34.7K | $59.3K | $73.7K | $102.8K | $131.3K | $165.4K | $175.5K | $151.6K | $402.2K | $-39.3K | $142.2K | $63.9K | · | · | · | |
| Other Non-op | $5.7K | $14.1K | $930 | $518 | $1.2K | $352 | $566 | $911 | $149.0K | $19.2K | $34.0K | $39.8K | $76.7K | $-66.7K | $-17.3K | · | |
| Net Income | $-2M | $-3M | $-3M | $-3M | $-5M | $-2M | $-1M | $-4M | $-2M | $-2M | $5M | $-6M | $-7M | $924.9K | $-5M | $3M | |
| EPS (Basic) | $-0.12 | $-0.31 | $-0.33 | $-0.30 | $-0.64 | $-0.20 | $-0.13 | $-0.50 | $-0.33 | $-0.11 | $1.04 | $-1.47 | $-1.93 | $0.28 | $-1.50 | $0.85 | |
| EPS (Diluted) | $-0.12 | $-0.31 | $-0.33 | $-0.30 | $-0.64 | $-0.20 | $-0.13 | $-0.50 | $-0.33 | $0.54 | $0.39 | $-1.47 | $-1.93 | $0.28 | $-1.50 | $0.33 | |
| Shares (Basic) | 17,727,747 | -17,220,582 | 9,116,172 | 8,740,382 | 8,357,143 | -15,150,448 | 8,121,499 | 8,121,499 | 6,671,382 | -7,956,277 | 4,570,843 | 3,886,309 | 3,717,472 | -7,185,942 | 3,642,215 | 3,638,383 | |
| Shares (Diluted) | 17,727,747 | -17,220,582 | 9,116,172 | 8,740,382 | 8,357,143 | -15,150,448 | 8,121,499 | 8,121,499 | 6,671,382 | -15,710,200 | 12,324,766 | 3,886,309 | 3,717,472 | -7,185,942 | 3,642,215 | 9,457,028 | |
| EBITDA | $-3M | · | $-4M | $-3M | $-5M | · | $-2M | $-2M | $-4M | · | $-3M | $-3M | $-6M | · | $-5M | $-5M |
Bilans 21
| Wskaźnik | Trend | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $3M | $2M | $602.4K | $2M | $1M | $547.9K | $1M | $2M | $1M | $884.4K | $2M | $2M | $2M | $2M | $7M | $18M | |
| Short-term Investments | $479.4K | $1M | $4M | $6M | $8M | $10M | $12M | $12M | $15M | $10M | $10M | $10M | $11M | $13M | $10M | · | |
| Receivables | $13.3K | $15.5K | $13.4K | $15.0K | $25.0K | $188.4K | $165.0K | $27.4K | $35.0K | $19.3K | $39.3K | $25.0K | $16.0K | $16.0K | $45.0K | $16.0K | |
| Prepaid Expense | $194.4K | $168.4K | $204.2K | $201.9K | $217.4K | $223.2K | $233.7K | $295.9K | $317.0K | $305.2K | $325.9K | $403.6K | $393.1K | $363.1K | $356.0K | $374.5K | |
| Current Assets | $4M | $3M | $5M | $8M | $9M | $11M | $14M | $15M | $17M | $11M | $13M | $12M | $13M | $15M | $17M | $18M | |
| PP&E (Net) | $328.8K | $358.8K | $309.5K | $339.7K | $370.0K | $362.9K | $378.4K | $345.8K | $365.0K | $356.1K | $306.3K | $314.1K | $304.1K | $261.0K | $231.3K | $266.8K | |
| PP&E (Gross) | · | $2M | · | · | · | $1M | · | · | · | $1M | · | · | · | $1M | · | · | |
| Accum. Depreciation | · | $1M | · | · | · | $1M | · | · | · | $1M | · | · | · | $935.8K | · | · | |
| Intangibles | $511.8K | $534.2K | $556.6K | $579.1K | $601.5K | $623.9K | $646.4K | $668.8K | $691.3K | $713.7K | $736.1K | $758.6K | $781.0K | $803.4K | $530.3K | $550.7K | |
| Total Assets | $5M | $4M | $6M | $9M | $10M | $12M | $15M | $16M | $18M | $13M | $14M | $13M | $14M | $16M | $18M | $19M | |
| Accounts Payable | $666.9K | $1M | $859.9K | $609.9K | $599.5K | $483.1K | $401.4K | $215.9K | $230.9K | $189.4K | $227.4K | $276.0K | $92.6K | $170.9K | $468.5K | $378.2K | |
| Accrued Liabilities | · | · | · | · | · | · | $682.2K | $447.6K | $338.3K | $711.7K | $549.0K | $386.3K | $233.0K | $130.1K | $114.6K | $114.7K | |
| Current Liabilities | $2M | $4M | $3M | $4M | $4M | $4M | $5M | $5M | $3M | $3M | $932.6K | $812.9K | $470.4K | $6M | $717.2K | $621.8K | |
| Capital Leases | · | · | · | · | · | · | · | · | · | · | $42.4K | $83.6K | $123.5K | $162.3K | $198.7K | $234.1K | |
| Total Liabilities | · | · | · | $4M | $4M | · | $5M | $5M | $3M | $3M | $975.0K | $896.4K | $593.9K | $6M | $915.9K | $855.8K | |
| Common Stock | $2.5K | $887 | $797 | $797 | $750 | $692 | $692 | $692 | $677 | $471 | $468 | $399 | $378 | $369 | $365 | $365 | |
| Paid-in Capital | $175M | $170M | $169M | $169M | $167M | $164M | $164M | $164M | $163M | $157M | $177M | $174M | $172M | $147M | $165M | $162M | |
| Retained Earnings | $-172M | $-170M | $-167M | $-164M | $-161M | $-156M | $-154M | $-153M | $-149M | $-147M | $-164M | $-161M | $-158M | $-136M | $-148M | $-144M | |
| Stockholders' Equity | $3M | $356.7K | $2M | $5M | $6M | $9M | $10M | $11M | $15M | $10M | $13M | $12M | $13M | $10M | $17M | $19M | |
| Liabilities + Equity | $5M | $4M | $6M | $9M | $10M | $12M | $15M | $16M | $18M | $13M | $14M | $13M | $14M | $16M | $18M | $19M | |
| Shares Outstanding | 25,478,170 | 8,876,242 | 7,978,117 | 7,978,117 | 7,504,780 | 6,919,919 | 6,919,919 | 6,919,919 | 6,769,919 | 4,706,917 | 4,667,641 | 3,982,608 | 3,767,615 | 3,677,775 | 3,646,450 | 3,643,709 |
Przepływy pieniężne 13
| Wskaźnik | Trend | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $52.4K | $52.8K | $52.6K | $52.7K | $51.8K | $50.4K | $48.3K | $47.7K | $42.7K | $42.7K | $42.1K | $41.5K | $39.4K | $31.8K | $31.2K | $31.5K | |
| Stock-based Comp | $290.2K | $447.9K | $399.9K | $468.7K | $2M | $175.6K | $284.2K | $324.3K | $2M | $1M | $1M | $2M | $3M | $3M | $9M | $6M | |
| Amort. of Intangibles | · | · | · | · | · | · | · | · | · | $22.4K | $22.4K | $22.4K | $22.4K | $18.9K | $20.4K | $20.4K | |
| Other Non-cash | · | · | · | · | · | · | · | · | · | · | · | · | $-43.1K | · | · | · | |
| Operating Cash Flow | $-4M | $-2M | $-3M | $-3M | $-3M | $-2M | $-2M | $-2M | $-2M | $-2M | $-1M | $-1M | $-2M | $-2M | $-1M | $-1M | |
| CapEx | · | $79.7K | $0 | $0 | $36.4K | $12.4K | $58.5K | · | · | $70.0K | $11.9K | $29.0K | $60.0K | $42.6K | $-24.6K | $137.7K | |
| Investing Cash Flow | $968.4K | $2M | $2M | $2M | $2M | $2M | $936.8K | $3M | $-5M | $-84.8K | $162.4K | $849.6K | $3M | $-3M | $-10M | $-137.7K | |
| Stock Issued | · | $1M | $0 | $927.3K | $1M | · | · | · | · | $83.1K | $9 | · | · | · | · | · | |
| Stock Repurchased | $0 | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Net Stock Activity | $0 | · | · | · | $1M | · | · | · | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | $4M | $923.2K | $-49.3K | $888.1K | $1M | $-126.3K | $0 | $-12.8K | $8M | $83.1K | $2M | · | · | · | · | · | |
| Net Change in Cash | $2M | $908.7K | $-952.8K | $326.5K | $680.9K | $-941.6K | $-762.8K | $1M | $272.7K | $-2M | $653.2K | $-52.8K | $159.9K | $-5M | $-11M | $-1M | |
| Free Cash Flow | · | · | · | · | $-3M | · | · | · | · | · | · | · | $-2M | · | · | · |
Rentowność 6
| Wskaźnik | Trend | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 68.1% | · | 10.4% | 97.1% | 88.4% | · | 92.2% | 46.9% | · | · | · | · | · | · | · | · | |
| Operating Margin | -14612.6% | · | -31432.3% | -1089.8% | -19230.1% | · | -979.0% | -1403.2% | -11740.7% | · | -10112.2% | -4831.9% | -18463.6% | · | -15895.5% | -6510.0% | |
| Net Margin | -9298.2% | · | -25748.1% | -875.8% | -21359.2% | · | -467.2% | -2289.7% | -6352.2% | · | -9529.3% | -4621.0% | -18160.5% | · | -16054.6% | -6575.6% | |
| EBITDA Margin | -14612.6% | · | -31432.3% | -1089.8% | -19230.1% | · | -979.0% | -1403.2% | -11740.7% | · | -10112.2% | -4831.9% | -18337.8% | · | -15895.5% | -6510.0% | |
| ROA | -28.8% | · | -30.1% | -21.6% | -37.8% | · | -7.7% | -27.4% | -13.9% | · | -18.4% | -18.2% | -32.5% | · | -46.3% | -41.9% | |
| ROE | -47.0% | · | -49.8% | -34.0% | -51.7% | · | -9.6% | -34.7% | -15.9% | · | -19.6% | -19.2% | -33.8% | · | -76.8% | -63.3% |
Płynność i wypłacalność 3
| Wskaźnik | Trend | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.4 | · | 1.4 | 2.1 | 2.2 | · | 2.9 | 2.8 | 4.9 | · | 13.5 | 14.8 | 27.2 | · | 23.5 | 29.5 | |
| Quick Ratio | 2.2 | · | 1.3 | 2.0 | 2.2 | · | 2.9 | 2.8 | 4.8 | · | 13.2 | 14.3 | 26.3 | · | 23.1 | 28.9 | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | · | · | · | · | · | -159.8 | · |
Efektywność 2
| Wskaźnik | Trend | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | |
| Receivables Turnover | 1.2 | · | 0.1 | 14.3 | 0.8 | · | 2.3 | 6.7 | 1.4 | · | 0.7 | 3.1 | 2.0 | · | 1.1 | 4.6 |
Wycena (TTM) 10
| Wskaźnik | Trend | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $363.3K | · | $573.7K | $651.0K | $382.7K | · | $388.4K | $219.3K | $161.5K | · | $155.5K | $195.9K | $147.4K | · | $124.1K | $110.1K | |
| Net Income TTM | $-13M | · | $-12M | $-13M | $-13M | · | $-3M | $-7M | $-10M | · | $-14M | $-15M | $-18M | · | $-15M | $-13M | |
| Market Cap | $7M | · | $12M | $13M | $13M | · | $12M | $14M | $9M | · | $8M | $18M | $13M | · | $12M | $11M | |
| P/E | -0.2 | · | -1.0 | -1.1 | -1.1 | · | -3.1 | -1.1 | -0.4 | · | -0.4 | -1.0 | -0.6 | · | · | · | |
| P/S | 19.1 | · | 20.2 | 20.4 | 34.9 | · | 31.0 | 64.1 | 57.8 | · | 53.7 | 89.7 | 86.9 | · | 94.9 | 97.6 | |
| P/B | 2.3 | · | 5.2 | 2.7 | 2.2 | · | 1.2 | 1.3 | 0.6 | · | 0.7 | 1.4 | 0.9 | · | 0.7 | 0.6 | |
| P / Tangible Book | 2.8 | · | 7.0 | 3.1 | 2.4 | · | 1.3 | 1.4 | 0.7 | · | 0.7 | 1.5 | 1.0 | · | 0.7 | 0.6 | |
| P / Cash Flow | -1.8 | · | · | · | -4.8 | · | · | · | -4.0 | · | · | · | -5.5 | · | · | · | |
| P / FCF | · | · | · | · | -4.7 | · | · | · | · | · | · | · | -5.3 | · | · | · | |
| Earnings Yield | -510.8% | · | -96.5% | -94.3% | -89.9% | · | -32.8% | -94.1% | -242.0% | · | -252.0% | -103.6% | -159.7% | · | · | · |
Sprawozdania finansowe Rachunek zysków i strat, bilans, przepływy pieniężne — roczne, ostatnie 5 lat
Rachunek zysków i strat
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Przychody | $359.7K | $401.0K | $145.8K | $119.8K | $46.0K |
| Marża Brutto % | 93.4% | 93.0% | — | — | — |
| Marża Operacyjna % | -4350.1% | -2881.6% | — | -15838.1% | -57191.0% |
| Zysk netto | $-14M | $-9M | $-10M | $-13M | $-44M |
| Rozwodniony EPS | $-1.58 | $-1.16 | $-2.47 | $-3.65 | — |
Bilans
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Dług / Kapitał Własny | — | — | — | — | 0.0 |
| Wskaźnik bieżący | 0.8 | 3.0 | — | 34.4 | 59.0 |
| Wskaźnik Szybkości | 0.8 | 2.9 | — | 33.5 | 57.8 |
Przepływy pieniężne
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Wolny przepływ pieniężny | $-11M | $-8M | — | $-6M | $-3M |
Moje wskaźniki Twoja osobista lista obserwowanych — wybrane wiersze z Pełnych Fundamentów
📊
Wybierz metryki, które są dla Ciebie ważne — kliknij ➕ obok dowolnego wiersza w Pełnych Fundamentach powyżej.
Twój wybór został zapisany i będzie Ci towarzyszył we wszystkich tickerach.
Właściciele instytucjonalni (13F) 25 emitentów · $626K łącznie · Na dzień 30 czerwca 2026
Instytucje, które zgłaszają posiadanie tych akcji w swoich kwartalnych zgłoszeniach SEC Form 13F. Tylko pozycje długie; pojedynczy zgłaszający może pojawić się dwukrotnie dla oddzielnych transz opcji. Duże przeciwstawne pozycje put/call zazwyczaj odzwierciedlają działalność market-makingową lub zabezpieczone zapasy, a nie przekonanie kierunkowe.
Aktywność instytucjonalna — Q2 2026 vs poprzedni kwartał
| Nowe pozycje | Zamknięte pozycje | Zwiększone | Zmniejszony | Zmiana liczby akcji netto |
|---|---|---|---|---|
| 10 (+6 vs poprzedni kw.) | 1 (-2 vs poprzedni kw.) | 4 (-1 vs poprzedni kw.) | 2 (+2 vs poprzedni kw.) | +1.5M |
Porównano z Q1 2026. Zgłoszenia SEC Form 13F są wymagane w ciągu 45 dni od końca kwartału plus krótki bufor dla spóźnionych zgłoszeń — kwartały mieszczące się jeszcze w tym terminie są pomijane na rzecz ostatniej w pełni zgłoszonej pary.
| Instytucja | Wartość | Akcje | % z śledzonych 13F | Typ |
|---|---|---|---|---|
| JANE STREET GROUP, LLC | $116 936 | 311 001 | 18,69% | Akcje |
| XTX Topco Ltd | $107 726 | 286 504 | 17,22% | Akcje |
| CITADEL ADVISORS LLC | $102 762 | 273 304 | 16,43% | Akcje |
| VANGUARD FIDUCIARY TRUST CO | $68 169 | 181 300 | 10,90% | Akcje |
| GEODE CAPITAL MANAGEMENT, LLC | $56 093 | 149 186 | 8,97% | Akcje |
| VANGUARD GROUP INC | $46 159 | 39 452 | 7,38% | Akcje |
| US FINANCIAL ADVISORS, LLC | $30 512 | 17 142 | 4,88% | Akcje |
| CITIGROUP INC | $23 960 | 63 724 | 3,83% | Akcje |
| WEALTH ALLIANCE, LLC | $15 040 | 40 000 | 2,40% | Akcje |
| STATE STREET CORP | $12 205 | 32 459 | 1,95% | Akcje |
| Keystone Financial Group | $10 754 | 28 600 | 1,72% | Akcje |
| NORTHERN TRUST CORP | $9 027 | 24 009 | 1,44% | Akcje |
| Creative Planning | $8 174 | 21 739 | 1,31% | Akcje |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $6 042 | 16 068 | 0,97% | Akcje |
| StoneX Group Inc. | $5 226 | 13 900 | 0,84% | Akcje |
| VANGUARD CAPITAL MANAGEMENT LLC | $4 879 | 12 977 | 0,78% | Akcje |
| OSAIC HOLDINGS, INC. | $760 | 2 000 | 0,12% | Akcje |
| Tower Research Capital LLC (TRC) | $550 | 1 463 | 0,09% | Akcje |
| HRT FINANCIAL LP | $267 | 710 590 | 0,04% | Akcje |
| SBI Securities Co., Ltd. | $263 | 699 | 0,04% | Akcje |
| Cornerstone Planning Group LLC | $3 | 11 | 0,00% | Akcje |
| TD Waterhouse Canada Inc. | $1 | 3 | 0,00% | Akcje |
| UBS Group AG | $0 | 1 | 0,00% | Akcje |
| Caitong International Asset Management Co., Ltd | $0 | 1 | 0,00% | Akcje |
| Parallel Advisors, LLC | $0 | 1 | 0,00% | Akcje |
Insiderzy spółki 19 insiderów · 8 dyrektorzy generalni · 12 dyrektorzy
| Insider | Rola | Ostatnia aktywność | Posiadane akcje | Kupna 12m | Sprzedaże 12m | Netto 12m |
|---|---|---|---|---|---|---|
| ALSTODT LANCE | President, CEO, COB | 6 października 2025 A | 187 497 | 0 | 0 | $0 |
| Mark Weinreb | CEO and Chairman of the Board | 23 czerwca 2017 A | 80 000 | 0 | 0 | $0 |
| Robert Eugene Kristal | Chief Financial Officer | 14 lutego 2025 A | — | 0 | 0 | $0 |
| Edward L. Field | President brtxDISC Division | 12 lipca 2017 A | — | 0 | 0 | $0 |
| Silva, Francisco | VP of Research and Development | 6 października 2025 A | 171 384 | 0 | 0 | $0 |
| Robert Paccasassi | VP, QA and Reg Compliance | 13 lutego 2024 A | — | 0 | 0 | $0 |
| Adam D. Bergstein | SVP, Planning and Business Dev | 19 stycznia 2018 A | — | 0 | 0 | $0 |
| Mandy D. Clark | VP of Operations | 10 sierpnia 2017 A | 0 | 0 | 0 | $0 |
| Nickolay V. Kukekov | Dyrektor | 14 lutego 2025 A | — | 0 | 0 | $0 |
| Patrick F. Williams | Dyrektor | 14 lutego 2025 A | — | 0 | 0 | $0 |
| David A Rosa | Dyrektor | 14 lutego 2025 A | — | 0 | 0 | $0 |
| Robert B Catell | Dyrektor | 9 maja 2018 P | 80 866 | 0 | 0 | $0 |
| John M Desmarais | Dyrektor | 17 listopada 2017 A | 493 398 | 0 | 0 | $0 |
| Charles S. Ryan | Dyrektor | 23 czerwca 2017 A | 42 917 | 0 | 0 | $0 |
| Paul Jude Tonna | Dyrektor | 23 czerwca 2017 A | 36 000 | 0 | 0 | $0 |
| Jeffrey A. Radov | Dyrektor | 23 czerwca 2017 A | 12 500 000 | 0 | 0 | $0 |
| Joseph B Swiader | Dyrektor | 31 marca 2015 A | 171 267 | 0 | 0 | $0 |
| Dale Broadrick | Posiadacz 10% | 28 października 2024 S | 445 933 | 0 | 0 | $0 |
| Joel San Antonio | — | 18 lutego 2014 A | 12 500 000 | 0 | 0 | $0 |
Insiderzy z zgłoszeń SEC Form 3/4/5; netto = tylko otwarty rynek P/S
Aktywiści i właściciele 5%+ 9 akcji
Inwestorzy, którzy złożyli SEC Schedule 13D — posiadanie beneficjentów powyżej 5% z zamiarem wpływania na emitenta (udziały aktywistów, kampanie zarządu, M&A). Każdy wiersz pokazuje najnowszy znany stan pozycji tego zgłaszającego.
| Zgłaszający | Złożono | Udział | Status | Cel | Zgłoszenie |
|---|---|---|---|---|---|
| ALSTODT LANCE | 19 lutego 2025 | 15,50% | Aneks | — | SEC |
| Silva, Francisco | 19 lutego 2025 | 15,10% | Aneks | — | SEC |
| Dale Broadrick ×10 zgłoszenia | 6 marca 2024 | — | Pierwotne zgłoszenie | — | SEC |
| Lance Alstodt ×3 zgłoszenia | 15 lutego 2024 | — | Pierwotne zgłoszenie | — | SEC |
| Francisco Silva ×3 zgłoszenia | 15 lutego 2024 | — | Pierwotne zgłoszenie | — | SEC |
| Mark Weinreb ×4 zgłoszenia | 26 listopada 2018 | — | Pierwotne zgłoszenie | — | SEC |
| John M. Desmarais ×3 zgłoszenia | 30 września 2016 | — | Pierwotne zgłoszenie | Kampania zarządu | SEC |
| Westbury (Bermuda) Ltd., Westbury Trust ×2 zgłoszenia | 9 grudnia 2015 | — | Pierwotne zgłoszenie | — | SEC |
| A. Jeffrey Radov | 19 lutego 2013 | — | Pierwotne zgłoszenie | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Posiadanie ETF-ów Posiadane przez 1 fundusz ETF
Waga odzwierciedla wyłącznie bezpośrednie udziały kapitałowe (N-PORT); fundusze oparte na dźwigni lub instrumentach pochodnych mogą posiadać dodatkowe ekspozycje na swapy, które nie są pokazane.
| Fundusz | Waga | Jednostki | Na dzień | Źródło |
|---|---|---|---|---|
| VXF · VANGUARD INDEX FUNDS | 0,00% | 12 977 SH | 19 sierpnia 2026 | Dziennie |